Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

capsule

capsule is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 20
Pipeline programs 478
News articles 0
Drug details — capsule
Class
—
Route
—
Patents
20
Programs
478
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

capsule is an FDA-listed pharmaceutical active ingredient.

Key facts

INN capsule

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. 042011 Phase 3 · George Institute for · Langerhans Cell Histiocytosis
  2. 116130 Phase 3 · Disc Medicine · Parkinson's disease
  3. 2019/2894 Phase 3 · George Institute for · Patients with High Risk Neuroblastoma
  4. 2023/3764 Phase 3 · George Institute for · Metastatic renal cell carcinoma (mRCC)
  5. 207495 Phase 3 · GSK Glaxo Smith · Relapsed/Refractory Multiple Myeloma
  6. 207499 Phase 3 · GSK Glaxo Smith · Relapsed/Refractory Multiple Myeloma
  7. 214828 Phase 3 · GSK Glaxo Smith · Multiple myeloma
  8. 4010-03-001 Phase 3 · TESARO Bio Netherlands · Recurrent or primary advanced (Stage III or IV) endometrial

Related patents

Browse patents

  1. WO 2025242584

    FORMULATION DE CAPSULE DE GÉLATINE MOLLE STABLE POUR ÉLINZANÉTANT

    Expires Wed Nov 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. WO 2025219169

    PRÉPARATIONS STABLES EN CAPSULES SOUPLES AVEC REMPLISSAGE LIQUIDE POUR PRINCIPES ACTIFS SENSIBLES À L'HUMIDITÉ

    Expires Wed Oct 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. WO 2025132620

    PRÉPARATIONS DE CAPSULE MOLLE STABLES À REMPLISSAGE SOLIDE POUR PRINCIPES ACTIFS SENSIBLES À L'HUMIDITÉ

    Expires Wed Jun 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12246096

    Self-assembled microcapsules with stimuli-responsive organic ligands

    Expires Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12084350

    Allotrope of carbon having increased electron delocalization

    Expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12023337

    Methods of treating cancer

    Expires Mon Jun 27 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11986534

    Treatment of anthrax with pegylated capsule-degrading enzyme

    Expires Mon May 16 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. WO 2024094329

    PRÉPARATION DE CAPSULE SOUS EMBALLAGE COQUE CONTENANT DU SULFATE D'ISAVUCONAZONIUM

    Expires Thu May 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11933866

    Magnetic resonance maps for analyzing brain tissue

    Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11892530

    Magnetic resonance maps for analyzing tissue

    Expires Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11872092

    Methods for surgical guidance in breast cancer surgery and lymph node dissection using two or more implantation devices comprising a capsule and a population of ultrasound-switchable fluorophores incorporated in the capsule

    Expires Mon Jan 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11820833

    Peptides that inhibit binding of EPCR to its ligand to treat inflammation

    Expires Mon Nov 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11786601

    Pegylated capsule-degrading enzyme for the treatment of anthrax

    Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11786479

    Nucleic acid nanocapsules for drug delivery and targeted gene knockdown

    Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11718530

    Allotrope of carbon having increased electron delocalization

    Expires Mon Aug 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11497793

    Compositions and methods for treating glioblastoma

    Expires Mon Nov 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11219636

    Compositions and methods for treating cancer

    Expires Mon Jan 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11103462

    Protein nanocapsules with detachable zwitterionic coating for protein delivery

    Expires Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11040040

    Methods of treating cancer

    Expires Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 10960016

    Capsules containing high doses of krill phospholipids

    Expires Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is capsule?

capsule is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.